CN104784596A - Traditional Chinese medicine for treating ankylosing spondylitis - Google Patents
Traditional Chinese medicine for treating ankylosing spondylitis Download PDFInfo
- Publication number
- CN104784596A CN104784596A CN201510147326.1A CN201510147326A CN104784596A CN 104784596 A CN104784596 A CN 104784596A CN 201510147326 A CN201510147326 A CN 201510147326A CN 104784596 A CN104784596 A CN 104784596A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traditional chinese
- chinese medicine
- caulis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicine preparations and particularly relates to a traditional Chinese medicine for treating ankylosing spondylitis. The traditional Chinese medicine is prepared by the following raw materials: raw radix astragalis, radix rehmanniae, rhizoma anemarrhenae, safflower, caulis sinomenii, Chinese starjasmine stem, caulis spatholobi, oldenlandia diffusa, polygonum cuspidatum, radix stemonae, rhizoma smilacis glabrae, pawpaw, radix scrophulariae, zaocys dhumnade, earthworm and meldar. A preparation method of the traditional Chinese medicine comprises the following steps: taking all the raw materials according to the mixing ratio, cleaning, uniformly mixing, adding 2-4 times of water by weight, decocting for 15-35 minutes, decocting for 2-4 times, combining a decoction solution, filtering and concentrating a filtrate into clear paste with a temperature of 70 DEG C and a relative density of 1.15-1.18. The traditional Chinese medicine has the benefits that the characteristics of various traditional Chinese medicines are integrated, the monarch medicines lead the medicine properties, clear away heat and remove toxicity, and reduce swelling and promote blood circulation, the ministerial medicines are auxiliary, increase medicine effects, dredge meridians under the efficacies of rattan traditional Chinese medicines and are sent to a stasis part; the cost is low, the treatment effect is high, and a piece of good news is brought to patients.
Description
Technical field
The invention belongs to field of traditional Chinese, be specifically related to a kind of Chinese medicine for the treatment of ankylosing spondylitis.
Background technology
Ankylosing spondylitis (ankylosin part spondylitis, AS) is that one mainly invades spinal column, and involves the chronic progressive external inflammatory diseases of sacroiliac joint and periarticular.Primary disease has another name called that Marie-str ü mpell is sick, VonBechterew is sick, poker back, rheumatoid centre type etc., now claims AS.The feature of AS is waist, neck, the inflammation of breast section joint of vertebral column and ligament and sacroiliac joint and ossified, and hip joint is usually got involved, and other periarticular also can occur inflammation.The general rheumatoid factor of primary disease is negative, thus with the subordination seronegativity rachiopathys such as Reiter syndrome, psoriatic arthritis, enteropathic arthritis.
The cause of disease of AS is illustrated at present not yet completely, and heredity, infection, immune environmental factors etc. are considered to main cause.
May there is a kind of pathogenic antigens in patients with ankylosing spondylitis body, make the health of patient constantly produce Relative antibody, cause the immunologic mechanism of body to destroy, thus bring out the outbreak of the state of an illness, be one of main cause of disease of ankylosing spondylitis.The major lesions position of patient is mainly at spinal column, and ridge is governor vessel institute mistake again, so this disease and governor vessel also have substantial connection.
From doctor trained in Western medicine angle, the sulfasalazine that treatment ankylosing spondylitis is conventional, methotrexate, nonsteroidal anti-inflammatory analgetic are as Ying Taiqing, diclofenac etc., the pain symptom of patient can be controlled, alleviate the mental pressure of patient, can also by the general symptom management of benefit match can be injected, but this all can not suppress the disease process of ankylosing spondylitis, and easily recurs after drug withdrawal.
From traditional Chinese medical science angle, ankylosing spondylitis is damp syndrome, damp and hot interior Sheng body constitution, and additional Shi Re Bing Pian infects, and pathogenic heat consumption is cloudy, and muscle tendon loses supports and causes contracture inflammation.
Summary of the invention
The technical problem to be solved in the present invention is the specific medicament solving ankylosing spondylitis, and this disease is superintended and directed empty to suffer from a deficiency of the kidney be this, and humid-heat stagnation is mark.Its medicine typing is not yet unification at present.The basis clinical experience for many years of ankylosing spondylitis, point active stage and catabasis two stage medications, can efficiently control.Select rattan class Drug therapy arthromyodynia, rattan network energy qualcomm meridian, draw all medicines and to go directly disease institute.
The present invention implements by the following technical solutions:
Treat a Chinese medicine for ankylosing spondylitis, its main component is counted by weight: Radix Astragali 12-18 part, Radix Rehmanniae 12-18 part, Rhizoma Anemarrhenae 7-13 part, Flos Carthami 7-13 part, Caulis Sinomenii 12-20 part, Caulis Trachelospermi 12-20 part, Caulis Spatholobi 12-20 part, Herba Hedyotidis Diffusae 12-18 part, Rhizoma Polygoni Cuspidati 12-18 part, Radix Stemonae 12-18 part, Rhizoma Smilacis Glabrae 12-18 part, Fructus Chaenomelis 7-13 part, Radix Scrophulariae 12-18 part, Zaocys 7-13 part, Pheretima 7-13 part, Fructus Lycii 7-13 part; Its preparation method is: get all raw materials by above-mentioned charge ratio and clean up rear mix homogeneously, adds two ~ tetra-times of weight parts waters, decocts 15 ~ 35 minutes, decoct 2 ~ 4 times, collecting decoction, filter, filtrate is condensed into the clear paste of 70 DEG C of relative densities 1.15 ~ 1.18.
Through the further research of inventor, component is optimized.
Above-mentioned main component is counted by weight: Radix Astragali 14-16 part, Radix Rehmanniae 14-16 part, Rhizoma Anemarrhenae 9-11 part, Flos Carthami 9-11 part, Caulis Sinomenii 15-17 part, Caulis Trachelospermi 15-17 part, Caulis Spatholobi 15-17 part, Herba Hedyotidis Diffusae 14-16 part, Rhizoma Polygoni Cuspidati 14-16 part, Radix Stemonae 14-16 part, Rhizoma Smilacis Glabrae 14-16 part, Fructus Chaenomelis 9-11 part, Radix Scrophulariae 14-16 part, Zaocys 9-11 part, Pheretima 9-11 part, Fructus Lycii 9-11 part.
Study for a long period of time through inventor, component is optimized further.
Above-mentioned main component is counted by weight: Radix Astragali 15 parts, 15 parts, the Radix Rehmanniae, the Rhizoma Anemarrhenae 10 parts, 10 parts, Flos Carthami, Caulis Sinomenii 16 parts, Caulis Trachelospermi 16 parts, Caulis Spatholobi 16 parts, Herba Hedyotidis Diffusae 15 parts, Rhizoma Polygoni Cuspidati 15 parts, the Radix Stemonae 15 parts, Rhizoma Smilacis Glabrae 15 parts, Fructus Chaenomelis 10 parts, Radix Scrophulariae 15 parts, Zaocys 10 parts, Pheretima 10 parts, Fructus Lycii 10 parts.
In the present invention, the performance effect of each Chinese herbal medicine is as follows:
Radix Astragali, the Radix Rehmanniae, the Rhizoma Anemarrhenae, Rhizoma Polygoni Cuspidati have the promoting the circulation of QI that promotes the production of body fluid, the kidney invigorating, effect of liver nourishing the moon; Rattan class medicine is the main force of this disease for the treatment of, and numbness processed of ventilating is drawn each medicine and to be gone directly disease institute: the main dredging the meridian of Caulis Sinomenii, foster kidney diuresis; Caulis Trachelospermi relaxing muscles and tendons to promote blood circulation, passages through which vital energy circulates contracture; Caulis Spatholobi removes blood stasis dispelling disease and has blood circulation-promoting functions concurrently; Herba Hedyotidis Diffusae, the Radix Stemonae, Rhizoma Smilacis Glabrae, Fructus Chaenomelis, Radix Scrophulariae can nourshing Yin and drynsessmoistening prescription, subduing swelling and detoxicating, heat clearing and inflammation relieving, can separate the heat-transformation of the dehumidifying stasis of blood, muscle tendon loses and support and cause the state of contracture inflammation; Zaocys, Pheretima, Flos Carthami, Fructus Lycii are blood circulation promoting medicines, immunity moderation, and blood stasis removing is searched and picked, and become, thus change rigid spine pathological changes to eliminate fiber; Multi-flavor medicine closes and controls, and collects drug effect in a place, how and not to mix, do not resist mutually, mutual potentiation.
The invention has the beneficial effects as follows: the characteristic combining various Chinese medicine, monarch drug dominates the property of medicine, heat-clearing and toxic substances removing, and detumescence is invigorated blood circulation, and ministerial drug is assisted a ruler in governing a country, and increase drug effect, under effect of liana kind Chinese herbs, dredging the meridian, delivers to the stagnant position of the stasis of blood medicine; Low cost, high curative effect, for sufferer brings glad tidings.
Detailed description of the invention
Embodiment 1
The present embodiment is a kind of Chinese medicine for the treatment of ankylosing spondylitis, and its main component is counted by weight: main component is counted by weight: Radix Astragali 15 parts, 15 parts, the Radix Rehmanniae, the Rhizoma Anemarrhenae 10 parts, 10 parts, Flos Carthami, Caulis Sinomenii 16 parts, Caulis Trachelospermi 16 parts, Caulis Spatholobi 16 parts, Herba Hedyotidis Diffusae 15 parts, Rhizoma Polygoni Cuspidati 15 parts, the Radix Stemonae 15 parts, Rhizoma Smilacis Glabrae 15 parts, Fructus Chaenomelis 10 parts, Radix Scrophulariae 15 parts, Zaocys 10 parts, Pheretima 10 parts, Fructus Lycii 10 parts.
Above-mentioned preparation method is: get all raw materials by above-mentioned charge ratio and clean up rear mix homogeneously, adds two times of weight parts waters, decocts 20 minutes, decocts 3 times, collecting decoction, filters, filtrate is condensed into the clear paste of 70 DEG C of relative densities 1.15 ~ 1.18.
Embodiment 2
The main component of the present embodiment is counted by weight: Radix Astragali 12g, Radix Rehmanniae 18g, Rhizoma Anemarrhenae 13g, Flos Carthami 13g, Caulis Sinomenii 16g, Caulis Trachelospermi 16g, Caulis Spatholobi 16g, Herba Hedyotidis Diffusae 12g, Rhizoma Polygoni Cuspidati 12g, Radix Stemonae 12g, Rhizoma Smilacis Glabrae 12g, Fructus Chaenomelis 7g, Radix Scrophulariae 15g, Zaocys 13g, Pheretima 7g, Fructus Lycii 7g.
Above-mentioned preparation method is: get all raw materials by above-mentioned charge ratio and clean up rear mix homogeneously, adds two times of weight parts waters, decocts 20 minutes, decocts 3 times, collecting decoction, filters, filtrate is condensed into the clear paste of 70 DEG C of relative densities 1.15 ~ 1.18.
Embodiment 3
The present embodiment is a kind of feasible program of embodiment 1, and its main component is counted by weight: Radix Astragali 18g, Radix Rehmanniae 16g, Rhizoma Anemarrhenae 12g, Flos Carthami 12g, Caulis Sinomenii 12g, Caulis Trachelospermi 12g, Caulis Spatholobi 20g, Herba Hedyotidis Diffusae 18g, Rhizoma Polygoni Cuspidati 12g, Radix Stemonae 15g, Rhizoma Smilacis Glabrae 15g, Fructus Chaenomelis 10g, Radix Scrophulariae 13g, Zaocys 10g, Pheretima 10g, Fructus Lycii 10g.
Above-mentioned preparation method is: get all raw materials by above-mentioned charge ratio and clean up rear mix homogeneously, adds two times of weight parts waters, decocts 20 minutes, decocts 3 times, collecting decoction, filters, filtrate is condensed into the clear paste of 70 DEG C of relative densities 1.15 ~ 1.18.
Embodiment 4
The present embodiment is a kind of feasible program of embodiment 1, and its main component is counted by weight: Radix Astragali 12g, Radix Rehmanniae 18g, Rhizoma Anemarrhenae 7g, Flos Carthami 7g, Caulis Sinomenii 20g, Caulis Trachelospermi 20g, Caulis Spatholobi 20g, Herba Hedyotidis Diffusae 15g, Rhizoma Polygoni Cuspidati 15g, Radix Stemonae 17g, Rhizoma Smilacis Glabrae 15g, Fructus Chaenomelis 10g, Radix Scrophulariae 18g, Zaocys 10g, Pheretima 9g, Fructus Lycii 9g.
Above-mentioned preparation method is: get all raw materials by above-mentioned charge ratio and clean up rear mix homogeneously, adds two times of weight parts waters, decocts 20 minutes, decocts 3 times, collecting decoction, filters, filtrate is condensed into the clear paste of 70 DEG C of relative densities 1.15 ~ 1.18.
Comparative example:
Outpatient service be diagnosed as ankylosing spondylitis patient 186 example, male 77 example, women 109 example, age characteristics 17-65 year.Random point two groups, wherein treatment group 102 example, matched group 84 example.
Treatment group uses the medicament obtained by the present invention, each 10g, every day 3 times; Matched group buccal English is too blue or green, 5 balls, 3 times on the one, and often organizing equal seven days is a course for the treatment of.
Contrast standard: diagnose weekly once, treatment conditioning one month, various transference cure is bitter without institute, follows up a case by regular visits to so far, has no repeatedly.
Comparative test result sees the following form:
Clinical observation on the therapeutic effect table
| Effectively | Invalid | Cure rate | |
| Treatment group 1 | 99 examples | 3 examples | 97％ |
| Treatment group 2 | 90 examples | 12 examples | 88％ |
| Treatment group 3 | 94 examples | 8 examples | 92％ |
| Treatment group 4 | 97 examples | 5 examples | 95％ |
| Matched group | 72 examples | 12 examples | 86％ |
From upper result, the Ying Taiqing that the medicament that the present invention treating three groups of uses obtain is taken than matched group can cure ankylosing spondylitis more effectively, and wherein the effect for the treatment of group 1 is best.
Claims (3)
1. treat a Chinese medicine for ankylosing spondylitis, it is characterized in that: its main component is counted by weight: Radix Astragali 12-18 part, Radix Rehmanniae 12-18 part, Rhizoma Anemarrhenae 7-13 part, Flos Carthami 7-13 part, Caulis Sinomenii 12-20 part, Caulis Trachelospermi 12-20 part, Caulis Spatholobi 12-20 part, Herba Hedyotidis Diffusae 12-18 part, Rhizoma Polygoni Cuspidati 12-18 part, Radix Stemonae 12-18 part, Rhizoma Smilacis Glabrae 12-18 part, Fructus Chaenomelis 7-13 part, Radix Scrophulariae 12-18 part, Zaocys 7-13 part, Pheretima 7-13 part, Fructus Lycii 7-13 part; Its preparation method is: get all raw materials by above-mentioned charge ratio and clean up rear mix homogeneously, adds two ~ tetra-times of weight parts waters, decocts 15 ~ 35 minutes, decoct 2 ~ 4 times, collecting decoction, filter, filtrate is condensed into the clear paste of 70 DEG C of relative densities 1.15 ~ 1.18.
2. a kind of Chinese medicine for the treatment of ankylosing spondylitis according to claim 1, is characterized in that: its main component is counted by weight: Radix Astragali 14-16 part, Radix Rehmanniae 14-16 part, Rhizoma Anemarrhenae 9-11 part, Flos Carthami 9-11 part, Caulis Sinomenii 15-17 part, Caulis Trachelospermi 15-17 part, Caulis Spatholobi 15-17 part, Herba Hedyotidis Diffusae 14-16 part, Rhizoma Polygoni Cuspidati 14-16 part, Radix Stemonae 14-16 part, Rhizoma Smilacis Glabrae 14-16 part, Fructus Chaenomelis 9-11 part, Radix Scrophulariae 14-16 part, Zaocys 9-11 part, Pheretima 9-11 part, Fructus Lycii 9-11 part.
3. a kind of Chinese medicine for the treatment of ankylosing spondylitis according to claim 1, is characterized in that: its main component is counted by weight: Radix Astragali 15 parts, 15 parts, the Radix Rehmanniae, the Rhizoma Anemarrhenae 10 parts, 10 parts, Flos Carthami, Caulis Sinomenii 16 parts, Caulis Trachelospermi 16 parts, Caulis Spatholobi 16 parts, Herba Hedyotidis Diffusae 15 parts, Rhizoma Polygoni Cuspidati 15 parts, the Radix Stemonae 15 parts, Rhizoma Smilacis Glabrae 15 parts, Fructus Chaenomelis 10 parts, Radix Scrophulariae 15 parts, Zaocys 10 parts, Pheretima 10 parts, Fructus Lycii 10 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510147326.1A CN104784596A (en) | 2015-03-31 | 2015-03-31 | Traditional Chinese medicine for treating ankylosing spondylitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510147326.1A CN104784596A (en) | 2015-03-31 | 2015-03-31 | Traditional Chinese medicine for treating ankylosing spondylitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104784596A true CN104784596A (en) | 2015-07-22 |
Family
ID=53550082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510147326.1A Pending CN104784596A (en) | 2015-03-31 | 2015-03-31 | Traditional Chinese medicine for treating ankylosing spondylitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104784596A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105663948A (en) * | 2016-03-14 | 2016-06-15 | 济南正骐生物科技有限公司 | Traditional Chinese medicine for treating urinary tract infection |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784208A (en) * | 2012-08-08 | 2012-11-21 | 冯安华 | Medicament for treating lumbar disc herniation and preparation method thereof |
| CN104069447A (en) * | 2014-07-24 | 2014-10-01 | 张晓丽 | Traditional Chinese medicine preparation for treating ankylosing spondylitis |
-
2015
- 2015-03-31 CN CN201510147326.1A patent/CN104784596A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784208A (en) * | 2012-08-08 | 2012-11-21 | 冯安华 | Medicament for treating lumbar disc herniation and preparation method thereof |
| CN104069447A (en) * | 2014-07-24 | 2014-10-01 | 张晓丽 | Traditional Chinese medicine preparation for treating ankylosing spondylitis |
Non-Patent Citations (1)
| Title |
|---|
| 陈欣 等: "龚正丰治疗强直性脊柱炎经验", 《安徽中医药大学学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105663948A (en) * | 2016-03-14 | 2016-06-15 | 济南正骐生物科技有限公司 | Traditional Chinese medicine for treating urinary tract infection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100415268C (en) | Medicinal wine for treating trachitis and pulmonary emphysema dyspneic cough | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN102423444B (en) | Traditional Chinese medicine preparation for treating rheumatism and internal lesion caused by overexertion and preparation method thereof | |
| CN101897930A (en) | Chinese medicinal herb for treating dysmenorrhoea disease | |
| CN102872313B (en) | Traditional Chinese medicine qi-tonifying and kidney-nourishing decoction for treating henoch-schonlein purpura nephritis | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN102872336B (en) | Traditional Chinese medicine for treating multiple myeloma | |
| CN104784596A (en) | Traditional Chinese medicine for treating ankylosing spondylitis | |
| CN101264218A (en) | Medicaments assembly for clearing heat and removing dampness, smoothing liver and invigorating spleen and preparation thereof | |
| CN104189764A (en) | Traditional Chinese medicinal preparation for treating intervention postoperative fever | |
| CN103655951A (en) | Chinese herbal preparation for treating acute pancreatitis as well as preparation method and application thereof | |
| CN103432467B (en) | Traditional Chinese medicine used for treating uremia and preparation method thereof | |
| CN102988650A (en) | Medicament for treating chronic nephritis and preparation method of medicament | |
| CN106177163A (en) | A kind of for decoction medicine treating pruritus and preparation method thereof | |
| CN101985013A (en) | Chinese herbal medicine for treating rheumatic arthritis | |
| CN103656463B (en) | A kind of Chinese medicine for the treatment of dysmenorrhea | |
| CN102631590B (en) | Method for preparing traditional Chinese medicine (TCM) for treating summer-heat and damp type colitis | |
| CN105267372A (en) | Traditional Chinese medicine granule for treating postoperative gastrointestinal dysfunction and its preparation method | |
| CN104873849A (en) | Traditional Chinese medicine for treating acute urethritis | |
| CN105012612A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN104523965A (en) | Nephritis treating traditional Chinese medicine composition | |
| CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
| CN105561001A (en) | Traditional Chinese medicine composition for treating alcoholic hepatitis | |
| CN106138421A (en) | Chinese medicine composition for the treatment of enteritis and preparation method and application | |
| CN105770815A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition for treating postpartum collapse and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150722 |